Insilico targeting of virus entry facilitator NRP1 to block SARS-CoV2 entry

Insilico targeting of virus entry facilitator NRP1 to block SARS-CoV2 entry

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Nousheen Bibi, Maleeha Shah, Shahzad Khan, Muhammad Shahzad Chohan, Mohammad Amjad Kamal
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11798527/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Insilico targeting of virus entry facilitator NRP1 to block SARS-CoV2 entry.
by: Nousheen Bibi, et al.
Published: (2025-01-01)

Evaluation of Paperless Electronic Data Entry and its Comparison with Manual Entry Method for Oral Health Assessment of Adults
by: Manu Batra, et al.
Published: (2023-04-01)

The Savvy Survey #15: Survey Responses and Data Entry
by: Milton G. Newberry, et al.
Published: (2014-09-01)

The resurrection as Christ's entry into his glory (Lk. 24:26)
by: Pieter G. R. de Villiers
Published: (2011-06-01)

Design and Prototyping of a Visitor Counter Guide for Single Entry and Exit.
by: Iragaba, Apollo
Published: (2025)

Requiring durations of therapy at the time of antibiotic order entry reduces antibiotic use
by: Megan R. Wright, et al.
Published: (2025-01-01)

Gemcitabine combined with baicalein exerts antiviral activity against PEDV by inhibiting the entry and replication phases
by: Yingge Zheng, et al.
Published: (2025-02-01)

Clinical Traits of SARS-CoV-2 Infection
by: O. Yu. Zolnikova, et al.
Published: (2020-12-01)

Human infection studies and the SARS-CoV-2 pandemic
by: Jörg Tremmel
Published: (2022-04-01)

Respiratory Protective Equipment Reconsiderations in the Age of SARS-CoV-2
by: Wei-Ren Ke, et al.
Published: (2022-01-01)

Inactivation of SARS-CoV-2 virus in saliva using a guanidium based transport medium suitable for RT-PCR diagnostic assays.
by: Sukalyani Banik, et al.
Published: (2021-01-01)

Stochastic Modelling of the Dynamics of the SARS-CoV-2 Epidemic: An Africa Perspective
by: Rasaki, Olawale Olanrewaju, et al.
Published: (2021)

Kaposi's sarcoma-associated herpesvirus (KSHV) gB dictates a low-pH endocytotic entry pathway as revealed by a dual-fluorescent virus system and a rhesus monkey rhadinovirus expressing KSHV gB.
by: Shanchuan Liu, et al.
Published: (2025-01-01)

Surveillance of SARS-CoV-2 variants in Henan, China from 2023 to 2024
by: Yun Song, et al.
Published: (2025-02-01)

Household transmission of SARS-CoV-2 in a rural area in South Africa
by: G Maimela, et al.
Published: (2024-02-01)

Simulations of pH and thermal effects on SARS-CoV-2 spike glycoprotein
by: Ziyuan Niu, et al.
Published: (2025-02-01)

Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01)

Host factor PLAC8 is required for pancreas infection by SARS-CoV-2
by: Lesly Ibargüen-González, et al.
Published: (2025-02-01)

RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2
by: Rang Feng, et al.
Published: (2025-02-01)

Transient severe myocarditis and intraventricular thrombus associated with SARS-CoV-2 vaccination
by: Alexander Loch, et al.
Published: (2023-06-01)

Collection of SARS-CoV-2 Virus from the Air of a Clinic within a University Student Health Care Center and Analyses of the Viral Genomic Sequence
by: John A. Lednicky, et al.
Published: (2020-05-01)

The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
by: Keneth Iceland, Kasozi
Published: (2021)

Bee Venom—A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections
by: Keneth Iceland, Kasozi, et al.
Published: (2021)

The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
by: Mohamed, Moubarak, et al.
Published: (2023)

Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease
by: Hiam Naiditch, et al.
Published: (2025-02-01)

Asymptomatic testing people for SARS-CoV-2 in healthcare facilities: A systematic review
by: Olabisi A. Oduwole, et al.
Published: (2025-01-01)

A systematic review of neurological symptoms and brain abnormalities in SARS-CoV-2 infections
by: Daniel Montoya, et al.
Published: (2023-08-01)

Isothermal Evaporation Rate of Deposited Liquid Aerosols and the SARS-CoV-2 Coronavirus Survival
by: Pavel S. Grinchuk, et al.
Published: (2020-11-01)

An Overview on the Role of Relative Humidity in Airborne Transmission of SARS-CoV-2 in Indoor Environments
by: Ajit Ahlawat, et al.
Published: (2020-07-01)

Soap and water cleaning versus bleach-based cleaners for eliminating SARS-CoV-2 infection
by: Ekong E. Udoh, et al.
Published: (2025-01-01)

Is differential cleaning needed for SARS-CoV-2 beyond standard procedures? A systematic review
by: Uduak Okomo, et al.
Published: (2025-01-01)

A data-driven semi-parametric model of SARS-CoV-2 transmission in the United States.
by: John M Drake, et al.
Published: (2023-11-01)

Simulation-based validation of a method to detect changes in SARS-CoV-2 reinfection risk.
by: Belinda Lombard, et al.
Published: (2025-02-01)

Registered COVID deaths in South Africa during the first year of the SARS-CoV-2 epidemic
by: T A Moultrie, et al.
Published: (2024-08-01)

Tracking the genetic diversity of SARS-CoV-2 variants in Nicaragua throughout the COVID-19 pandemic
by: Gerald Vásquez Alemán, et al.
Published: (2025-02-01)

SARS-CoV-2 Remained Airborne for a Prolonged Time in a Lockdown Confined Space
by: Xinyue Li, et al.
Published: (2022-01-01)

Surface plasmon resonance biosensors for SARS-CoV-2 sensing: The role of silicon nitride and graphene
by: Talia Tene, et al.
Published: (2025-05-01)

Filtration efficiency of medical and community face masks against particles carrying SARS-CoV-2
by: Sara Dalvand, et al.
Published: (2024-12-01)

University Lecturers and Students Could Help in Community Education About SARS-CoV-2 Infection in Uganda.
by: Echoru, Isaac, et al.
Published: (2023)

In vivo production of engineered ACE2 decoy protects lungs from SARS-CoV-2 infection
by: Yuta Suzuki, et al.
Published: (2025-03-01)